Discover 1,438 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,438
Active & Responsive
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
for
Primary Biliary Cholangitis
Location: Seattle WA, Vancouver, Calgary, Sacramento CA,
Sponsor: Ipsen
Sex: All
Age: 0+
Code: NCT06447168
Recruiting
Active & Responsive
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
for
Primary Sclerosing Cholangitis
Location: Seattle WA, Englewood CO, Littleton CO, Coronado CA,
Sponsor: Ipsen
Sex: All
Age: 18 - 70+
Code: NCT07387549
Phase3, Recruiting
Active & Responsive
VTP-1000 in Adults With Celiac Disease
for
Celiac Disease
Location: Seattle WA, West Jordan UT, Los Angeles CA,
Sponsor: Barinthus Biotherapeutics
Sex: All
Age: 18 - 70
Code: NCT06310291
Early_phase1, Recruiting
Active & Responsive
PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML
A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations
for
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF),
Location: Seattle WA, Los Angeles CA, San Diego CA, Milwaukee WI,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 0+
Code: NCT05788536
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
for
Central Nervous System Tumor, Diffuse Intrinsic Pontine Glioma,
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 1 - 26
Code: NCT04185038
Phase1, Recruiting
Active & Responsive
Advancing Transplantation Outcomes in Children
for
Kidney Transplant
Location: Seattle WA, Los Angeles CA, Aurora CO, San Diego CA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 13 - 20
Code: NCT06055608
Phase2, Recruiting
Active & Responsive
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
Location: Seattle WA, Mountain View CA, Palo Alto CA,
Sponsor: University of Utah
Sex: All
Age: 0 - 18
Code: NCT05471908
Recruiting
Active & Responsive
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Seattle WA, Portland OR, Calgary, San Francisco CA,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT05183035
Phase3, Recruiting
Active & Responsive
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
for
Type 1 Diabetes, Diabetic Kidney Disease,
Location: Seattle WA
Sponsor: Kalie Tommerdahl
Sex: All
Age: 12 - 25
Code: NCT05065372
Phase1, Recruiting
Active & Responsive
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
for
Lymphoid Leukemia
Location: Seattle WA, Portland OR, San Francisco CA, Palo Alto CA,
Sponsor: Stanford University
Sex: All
Age: 0 - 26
Code: NCT05865301
Recruiting
Active & Responsive
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block
for
Heart Block Complete, Heart Block Second Degree
Location: Seattle WA, San Francisco CA, Denver CO, Phoenix AZ,
Sponsor: The Hospital for Sick Children
Sex: Female
Age: 16 - 50
Code: NCT04559425
Recruiting
Active & Responsive
Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)
for
End Stage Renal Disease
Location: Seattle WA, Loma Linda CA, Kansas City MO,
Sponsor: Rockwell Medical Technologies, Inc.
Sex: All
Age: 0 - 17
Code: NCT04239391
Phase3, Recruiting
Active & Responsive
Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products
for
CAR T Cell, CAR T Cell Therapy
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 0+
Code: NCT07424157
Recruiting
Active & Responsive
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
for
Type 1 Diabetes, New Onset
Location: Seattle WA, San Francisco CA, Minneapolis MN,
Sponsor: City of Hope Medical Center
Sex: All
Age: 9 - 20
Code: NCT07061574
Phase1, Phase2, Recruiting
Active & Responsive
EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Seattle WA, Portland OR, St Louis MO, Houston TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 70+
Code: NCT06997588
Phase2, Recruiting
Active & Responsive
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
for
Cystic Fibrosis
Location: Seattle WA, Denver CO, Aurora CO, Kansas City KS,
Sponsor: Boston Children's Hospital
Sex: All
Age: 6+
Code: NCT06683092
Recruiting
Active & Responsive
Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes